Kshitij Rishi
Co‑founder & COO at 4baseCare, precision oncology operations leader
Bengaluru, Karnataka, India
Summary
Operational and partnerships leader in precision oncology who co‑founded 4baseCare and runs COO responsibilities—building strategic collaborations, real‑world evidence programs and patient engagement to translate clinico‑genomic data into actionable care. 4basecare+2
Background in healthcare education, operations and consulting with multi‑year experience at GE Healthcare and prior leadership/consulting roles (including Deloitte), bringing commercialization and training experience to a genomics startup context. f6s+1
Contributor to applied genomics research and clinical publications related to liquid biopsy, combined tissue/liquid profiling and real‑world genomic datasets for South Asian populations, reflecting involvement in both product development and research outputs. google+1
Founder focused on population‑specific genomics and affordability—helped develop India‑focused gene panels and patient‑centric genomic services aimed at reducing cost barriers and increasing locally relevant genomic data for precision oncology. thehindu+1
Work
Education
Projects
Writing
Utility of combined solid and liquid biopsy for molecular profiling in lung adenocarcinoma: Insights from a real-world case
January 1, 2025A clinical case/report describing combined tissue and liquid biopsy approaches for molecular profiling in lung adenocarcinoma; Kshitij Rishi appears as a co‑author on related conference/journal entries.
Exploring the clinical utility of liquid biopsy with cfDNA in cancer: A systematic review
January 1, 2024Systematic review on the clinical utility of cell‑free DNA (cfDNA) liquid biopsy methods in cancer care; listed among publications with Kshitij Rishi as co‑author.
Notes
KVKarthik Varadasaid
KRKshitij Rishi
is among the most knowledgeable people they know in oncology or specialty pharmaceuticals.Jul 1, 2025